Literature DB >> 25155499

Myocardial infarctions and other acute coronary syndromes in rare congenital bleeding disorders: a critical analysis of all reported cases.

Antonio Girolami1, Silvia Ferrari2, Luisa Sambado2, Edoardo Peroni2, Elisabetta Cosi2.   

Abstract

OBJECTIVE: To investigate the occurrence of myocardial infarction or other acute coronary syndromes in rare congenital bleeding disorders. PATIENTS: All patients with factor I (FI), factor II (FII), factor V (FV), factor VII (FVII), factor X (FX), factor XI (FXI), or factor XIII (FXIII) deficiency or abnormality reported to have presented a myocardial infarction or another acute coronary syndrome were investigated. The condition had to be demonstrated by objective means, including a coronary/angiography. Cases of stable angina were excluded.
RESULTS: A total of 53 patients (4 had FI, 2 had FV, 2 had FVII, 36 had FXI, 1 had FXIII deficiency, and 8 patients had platelet disorders) met the inclusion criteria . No patient with FII or FX deficiency and acute coronary disease met the inclusion criteria. In the majority of patients, common risk factors were present, namely hypertension, hypercholesterolemia, smoking, and diabetes. Replacement therapy was involved in 5 cases.
CONCLUSION: The congenital hypocoagulability present in these patients was unable to allow a protection from acute coronary diseases. The significance of the findings is discussed.
© The Author(s) 2014.

Entities:  

Keywords:  acute coronary syndromes; myocardial infarctions; rare disorders

Mesh:

Substances:

Year:  2014        PMID: 25155499     DOI: 10.1177/1076029614548056

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  1 in total

1.  Major cardiac surgery with recombinant FIX Fc fusion protein replacement in hemophilia B: a case report.

Authors:  Jan-Paul Bohn; Anna Fiala; Sebastian Bachmann; Christian Irsara; Dominik Wolf; Clemens Feistritzer
Journal:  Ther Adv Hematol       Date:  2022-07-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.